| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790030 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
We demonstrated the clinical value of the integration of LVI and VH in a prognostic model for the prediction of MIBC. Indeed, our tool provides superior individualized risk estimation of progression facilitating decision-making regarding early RC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David M.D., Mohammad M.D., Martin M.D., Robin PhD., Beat M.D., Shoji M.D., Andrea M.D., Francesco M.D., Alberto M.D., Pierre I. M.D., Killian M. M.D., Morgan M.D., Shahrokh F. M.D.,